Sulfuric Acid

Sulfuric Acid

SCHEMBL1697123

CCCCCCCC[N+](CCCCCCCC)(CCCCCCCC)CCCCCCCC.O=S(=O)([O-])O

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CYP51cyp51Acyp51c

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 3/20 0.62
ALDH1A1 P00352 1/20 0.59
TP53 P04637 1/20 0.59
CYP3A4 P08684 1/20 0.59
ALOX15 P16050 1/20 0.59
TSHR P16473 1/20 0.59
ALOX12 P18054 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
HIF1A Q16665 1/20 0.59
HSD17B10 Q99714 1/20 0.59
SLC22A2 O15244 1/20 0.57
DNM1 Q05193 6/20 0.54
LSS P48449 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL11119601 1.00 SLC22A1 (0.62) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Tetrahexylammonium SCHEMBL444047 1.00 SLC22A1 (0.62) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Sulfuric Acid SCHEMBL4372101 1.00 SLC22A1 (0.62) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Sulfuric Acid SCHEMBL9792104 0.98 SLC22A1 (0.59) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Sulfuric Acid SCHEMBL11840392 0.98 SLC22A1 (0.59) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Tetrahexylammonium SCHEMBL3641189 0.98 SLC22A1 (0.59) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Sulfuric Acid SCHEMBL11534969 0.98 SLC22A1 (0.59) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Tetrapentylammonium SCHEMBL6261133 0.98 SLC22A1 (0.60) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Sulfuric Acid SCHEMBL6260571 0.96 SLC22A1 (0.56) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Sulfuric Acid SCHEMBL6260172 0.96 SLC22A1 (0.56) SLC22A1ALDH1A1TP53CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 131 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250171409-A1 PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES ADAMA MAKHTESHIM LTD. (IL) 2025-05-29 US claimed
EP-4460499-A1 PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES ADAMA MAKHTESHIM LTD. (IL) 2024-11-13 EP claimed
CN-118556052-A Preparation method of indoxacarb and intermediate thereof 安道麦马克西姆有限公司 2024-08-27 CN claimed
WO-2023131943-A1 PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES ADAMA MAKHTESHIM LTD. (IL) 2023-07-13 WO claimed
EP-3658523-B1 PROCESS FOR PREPARING (Z)-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE CHEMOURS CO FC LLC (US) 2023-04-26 EP claimed
CN-113882140-A Preparation method of antibacterial fiber and fiber or clothing thereof 深圳市中盛丽达科技有限公司 2022-01-04 CN claimed
US-20210017106-A1 PROCESS FOR PREPARING (Z)-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE THE CHEMOURS COMPANY FC, LLC (US) 2021-01-21 US claimed
EP-3658523-A1 PROCESS FOR PREPARING (Z)-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE The Chemours Company FC, LLC (US) 2020-06-03 EP claimed
US-20190031582-A1 Process for Preparing (Z)-1,1,1,4,4,4-Hexafluoro-2-Butene JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT 2019-01-31 US claimed
WO-2019023572-A1 PROCESS FOR PREPARING (Z)-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE THE CHEMOURS COMPANY FC, LLC (US) 2019-01-31 WO claimed
EP-2922809-A1 DEHYDROCHLORINATION OF CHLORINATED REACTANTS TO PRODUCE 1,1,1,4,4,4-HEXAFLUORO-2-BUTYNE E. I. du Pont de Nemours and Company (US) 2015-09-30 EP claimed
US-20150203423-A1 Dehydrochlorination of HCFC -336 Isomers to 1,1,1,4,4,4-Hexafluoro-2-Butyne E I DU PONT DE NEMOURS AND COMPANY (US) 2015-07-23 US claimed
US-7696366-B2 Production process of bifunctional epoxy monomer by selective oxidation of diolefin compound SHOWA DENKO K.K. (JP) 2010-04-13 US claimed
US-7541312-B2 Porous carbons from carbohydrates TDA RESEARCH, INC. (US) 2009-06-02 US claimed
EP-1725497-A4 POROUS CARBONS FROM CARBOHYDRATES TDA RESEARCH INC (US) 2008-11-05 EP claimed
EP-1725497-A2 POROUS CARBONS FROM CARBOHYDRATES TDA RESEARCH, INC. (US) 2006-11-29 EP claimed
US-20060216828-A1 Rapid-response reversible dry surface CO2 detector MERCURY ENTERPRISE, INC. 2006-09-28 US claimed
WO-2005089145-A2 POROUS CARBONS FROM CARBOHYDRATES TDA RESEARCH, INC. (US) 2005-09-29 WO claimed
US-20050207962-A1 Porous carbons from carbohydrates TDA RESEARCH, INC. (US) 2005-09-22 US claimed
EP-4747225-A2 A PROCESS TO PRODUCE 1252ZC FROM 1230XA OR 252DC AND COMPOSITIONS THEREOF The Chemours Company FC, LLC (US) 2026-05-27 EP disclosed
EP-4747220-A1 SYSTEMS AND PROCESSES FOR THE PRODUCTION OF Z-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE The Chemours Company FC, LLC (US) 2026-05-27 EP disclosed
US-20260042721-A1 PROCESS FOR PRODUCING 1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE THE CHEMOURS COMPANY FC, LLC (US) 2026-02-12 US disclosed
US-12421180-B2 Processes for producing Z-1,1,1,4,4,4-hexafluorobut-2-ene and intermediates for producing same THE CHEMOURS COMPANY FC, LLC (US) 2025-09-23 US disclosed
US-12421181-B2 Process for producing 1,1,1,4,4,4-hexafluorobut-2-ene THE CHEMOURS COMPANY FC, LLC (US) 2025-09-23 US disclosed
US-20250242063-A1 METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF LANTHEUS MEDICAL IMAGING, INC. (US) 2025-07-31 US disclosed
US-20250171409-A1 PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES ADAMA MAKHTESHIM LTD. (IL) 2025-05-29 US disclosed
EP-4554931-A1 PROCESS FOR PREPARING SUBSTITUTED BENZAMIDES ADAMA MAKHTESHIM LTD. (IL) 2025-05-21 EP disclosed
US-12286386-B2 Process to produce (Z)-1,1,1,4,4,4-hexafluoro-2-butene and intermediates THE CHEMOURS COMPANY FC, LLC (US) 2025-04-29 US disclosed
CN-119698408-A Process for preparing substituted benzamides 安道麦马克西姆有限公司 2025-03-25 CN disclosed
WO-2025019751-A1 SYSTEMS AND PROCESSES FOR THE PRODUCTION OF Z-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE THE CHEMOURS COMPANY FC, LLC (US) 2025-01-23 WO disclosed
WO-2025019191-A2 A PROCESS TO PRODUCE 1252ZC FROM 1230XA OR 252DC AND COMPOSITIONS THEREOF THE CHEMOURS COMPANY FC, LLC (US) 2025-01-23 WO disclosed
WO-2025019754-A1 PROCESSES FOR THE PRODUCTION OF HEXAFLUORO-2-BUTYNE AND COMPOSITIONS THEREOF THE CHEMOURS COMPANY FC, LLC (US) 2025-01-23 WO disclosed
CN-115210202-B Process for the preparation of (Z) -1, 4-hexafluoro-2-butene and intermediates 科慕埃弗西有限公司 2025-01-21 CN disclosed
EP-3947326-B1 PROCESSES FOR PRODUCING Z-1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE AND INTERMEDIATES FOR PRODUCING SAME CHEMOURS CO FC LLC (US) 2025-01-15 EP disclosed
CN-113661156-B Process for the preparation of 1, 4-hexafluorobut-2-ene 科慕埃弗西有限公司 2024-11-26 CN disclosed
EP-4460499-A1 PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES ADAMA MAKHTESHIM LTD. (IL) 2024-11-13 EP disclosed
EP-4114814-B1 PROCESS TO PRODUCE (Z)-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE AND INTERMEDIATES CHEMOURS CO FC LLC (US) 2024-09-25 EP disclosed
CN-118556052-A Preparation method of indoxacarb and intermediate thereof 安道麦马克西姆有限公司 2024-08-27 CN disclosed
CN-113939492-B Process for preparing Z-1, 4-hexafluorobut-2-ene and intermediates for preparing the same 科慕埃弗西有限公司 2024-05-17 CN disclosed
CN-113677650-B Process for preparing Z-1, 4-hexafluorobut-2-ene and intermediates for preparing the same 科慕埃弗西有限公司 2024-04-12 CN disclosed
CN-113661154-B Process for preparing Z-1, 4-hexafluorobut-2-ene and intermediates for preparing the same 科慕埃弗西有限公司 2024-04-09 CN disclosed
US-11912639-B2 Processes for producing Z-1,1,1,4,4,4-hexafluorobut-2-ene and intermediates for producing same THE CHEMOURS COMPANY FC, LLC (US) 2024-02-27 US disclosed
WO-2024013736-A1 PROCESS FOR PREPARING SUBSTITUTED BENZAMIDES ADAMA MAKHTESHIM LTD. (IL) 2024-01-18 WO disclosed
CN-111201211-B Process for the preparation of (Z) -1, 4-hexafluoro-2-butene 科慕埃弗西有限公司 2023-12-05 CN disclosed
WO-2023131943-A1 PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES ADAMA MAKHTESHIM LTD. (IL) 2023-07-13 WO disclosed
EP-3947331-B1 PROCESSES FOR PRODUCING Z-1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE AND INTERMEDIATES FOR PRODUCING SAME CHEMOURS CO FC LLC (US) 2023-05-31 EP disclosed
EP-3947327-B1 PROCESSES FOR PRODUCING Z-1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE AND INTERMEDIATES FOR PRODUCING SAME CHEMOURS CO FC LLC (US) 2023-05-31 EP disclosed
EP-3658523-B1 PROCESS FOR PREPARING (Z)-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE CHEMOURS CO FC LLC (US) 2023-04-26 EP disclosed
EP-3102556-B1 INTEGRATED PROCESS FOR THE PRODUCTION OF Z-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE CHEMOURS CO FC LLC (US) 2023-03-29 EP disclosed
CN-111018657-B Integrated method for preparing Z-1,1,1,4,4,4-hexafluoro-2-butene 科慕埃弗西有限公司 2023-03-10 CN disclosed
US-20230074227-A1 PROCESS TO PRODUCE (Z)-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE AND INTERMEDIATES THE CHEMOURS COMPANY FC, LLC (US) 2023-03-09 US disclosed
EP-4114814-A1 PROCESS TO PRODUCE (Z)-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE AND INTERMEDIATES The Chemours Company FC, LLC (US) 2023-01-11 EP disclosed
US-11499008-B2 Functionalized poly (propylene fumarate) polymers made by ring opening polymerization using magnesium catalysts UNIVERSITY OF AKRON (US) 2022-11-15 US disclosed
CN-115210202-A Process for preparing (Z) -1,1,1,4,4,4-hexafluoro-2-butene and intermediates 科慕埃弗西有限公司 2022-10-18 CN disclosed
EP-4046990-A1 METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF Lantheus Medical Imaging, Inc. (US) 2022-08-24 EP disclosed
US-20220194882-A1 PROCESSES FOR PRODUCING Z-1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE AND INTERMEDIATES FOR PRODUCING SAME THE CHEMOURS COMPANY FC, LLC (US) 2022-06-23 US disclosed
US-20220194881-A1 PROCESSES FOR PRODUCING Z-1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE AND INTERMEDIATES FOR PRODUCING SAME THE CHEMOURS COMPANY FC, LLC (US) 2022-06-23 US disclosed
US-20220194879-A1 PROCESSES FOR PRODUCING Z-1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE AND INTERMEDIATES FOR PRODUCING SAME THE CHEMOURS COMPANY FC, LLC (US) 2022-06-23 US disclosed
US-20220162141-A1 PROCESS FOR PRODUCING 1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE THE CHEMOURS COMPANY FC, LLC (US) 2022-05-26 US disclosed
CN-110366434-B Functionalized poly (propylene fumarate) polymers prepared by ring opening polymerization using magnesium catalysts 阿克伦大学 2022-04-05 CN disclosed
EP-3947327-A1 PROCESSES FOR PRODUCING Z-1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE AND INTERMEDIATES FOR PRODUCING SAME The Chemours Company FC, LLC (US) 2022-02-09 EP disclosed
EP-3947330-A1 PROCESS FOR PRODUCING 1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE The Chemours Company FC, LLC (US) 2022-02-09 EP disclosed
EP-3947326-A1 PROCESSES FOR PRODUCING Z-1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE AND INTERMEDIATES FOR PRODUCING SAME The Chemours Company FC, LLC (US) 2022-02-09 EP disclosed
EP-3947331-A1 PROCESSES FOR PRODUCING Z-1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE AND INTERMEDIATES FOR PRODUCING SAME The Chemours Company FC, LLC (US) 2022-02-09 EP disclosed
CN-113882140-A Preparation method of antibacterial fiber and fiber or clothing thereof 深圳市中盛丽达科技有限公司 2022-01-04 CN disclosed
CN-109200296-B Method and apparatus for synthesizing imaging agents and intermediates thereof 兰休斯医疗成像公司 2021-12-14 CN disclosed
CN-113677650-A Process for preparing Z-1, 1, 1, 4, 4, 4-hexafluorobut-2-ene and intermediates useful for preparing same 科慕埃弗西有限公司 2021-11-19 CN disclosed
WO-2021178507-A1 PROCESS TO PRODUCE (Z)-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE AND INTERMEDIATES THE CHEMOURS COMPANY FC, LLC (US) 2021-09-10 WO disclosed
CN-113058046-A Method and apparatus for synthesizing imaging agents and intermediates thereof 兰休斯医疗成像公司 2021-07-02 CN disclosed
US-20210187131-A1 METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF LANTHEUS MEDICAL IMAGING, INC. (US) 2021-06-24 US disclosed
US-10991868-B2 Thermoelectric conversion element FUJIFILM CORPORATION (JP) 2021-04-27 US disclosed
US-20210017106-A1 PROCESS FOR PREPARING (Z)-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE THE CHEMOURS COMPANY FC, LLC (US) 2021-01-21 US disclosed
US-10842892-B2 Methods and apparatus for synthesizing imaging agents, and intermediates thereof LANTHEUS MEDICAL IMAGING, INC. (US) 2020-11-24 US disclosed
WO-2020206247-A1 PROCESS FOR PRODUCING 1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE THE CHEMOURS COMPANY FC, LLC (US) 2020-10-08 WO disclosed
WO-2020206335-A1 PROCESSES FOR PRODUCING Z-1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE AND INTERMEDIATES FOR PRODUCING SAME THE CHEMOURS COMPANY FC, LLC (US) 2020-10-08 WO disclosed
WO-2020206322-A1 PROCESSES FOR PRODUCING Z-1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE AND INTERMEDIATES FOR PRODUCING SAME THE CHEMOURS COMPANY FC, LLC (US) 2020-10-08 WO disclosed
WO-2020206279-A1 PROCESSES FOR PRODUCING Z-1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE AND INTERMEDIATES FOR PRODUCING SAME THE CHEMOURS COMPANY FC, LLC (US) 2020-10-08 WO disclosed
EP-3658523-A1 PROCESS FOR PREPARING (Z)-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE The Chemours Company FC, LLC (US) 2020-06-03 EP disclosed
CN-111201211-A Process for preparing (Z) -1, 1, 1, 4, 4, 4-hexafluoro-2-butene 科慕埃弗西有限公司 2020-05-26 CN disclosed
US-10654777-B2 Integrated process for the production of Z-1,1,1,4,4,4-hexafluoro-2-butene THE CHEMOURS COMPANY FC, LLC (US) 2020-05-19 US disclosed
US-20190290788-A1 METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF LANTHEUS MEDICAL IMAGING, INC. (US) 2019-09-26 US disclosed
US-20190248719-A1 INTEGRATED PROCESS FOR THE PRODUCTION OF Z-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT 2019-08-15 US disclosed
US-20190112192-A1 THERMOELECTRIC CONVERSION ELEMENT FUJIFILM CORPORATION (JP) 2019-04-18 US disclosed
US-10227276-B2 Integrated process for the production of Z-1,1,1,4,4,4-hexafluoro-2-butene THE CHEMOURS COMPANY FC, LLC (US) 2019-03-12 US disclosed
US-20190031582-A1 Process for Preparing (Z)-1,1,1,4,4,4-Hexafluoro-2-Butene JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT 2019-01-31 US disclosed
WO-2019023572-A1 PROCESS FOR PREPARING (Z)-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE THE CHEMOURS COMPANY FC, LLC (US) 2019-01-31 WO disclosed
US-20180362421-A1 INTEGRATED PROCESS FOR THE PRODUCTION OF Z-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT 2018-12-20 US disclosed
US-10099976-B2 Integrated process for the production of Z-1,1,1,4,4,4-hexafluoro-2-butene THE CHEMOURS COMPANY FC, LLC (US) 2018-10-16 US disclosed
US-10022462-B2 Methods and apparatus for synthesizing imaging agents, and intermediates thereof LANTHEUS MEDICAL IMAGING, INC. (US) 2018-07-17 US disclosed
EP-3323810-A2 AUTOMATED REACTION SYSTEM, CASSETTE AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS Lantheus Medical Imaging, Inc. (US) 2018-05-23 EP disclosed
US-20170369403-A1 INTEGRATED PROCESS FOR THE PRODUCTION OF Z-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE THE CHEMOURS COMPANY FC, LLC 2017-12-28 US disclosed
US-20170258947-A1 METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF LANTHEUS MEDICAL IMAGING, INC. (US) 2017-09-14 US disclosed
US-9758452-B2 Integrated process for the production of Z-1,1,1,4,4,4-hexafluoro-2-butene THE CHEMOURS COMPANY FC, LLC (US) 2017-09-12 US disclosed
EP-2534136-B1 METHODS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF LANTHEUS MEDICAL IMAGING INC (US) 2017-09-06 EP disclosed
US-9603951-B2 Methods and apparatus for synthesizing imaging agents, and intermediates thereof LANTHEUS MEDICAL IMAGING, INC. (US) 2017-03-28 US disclosed
US-20170015607-A1 PROCESSES FOR THE PRODUCTION OF Z 1,1,1,4,4,4 HEXAFLUORO 2-BUTENE JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT 2017-01-19 US disclosed
EP-3102556-A1 INTEGRATED PROCESS FOR THE PRODUCTION OF Z-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE The Chemours Company FC, LLC (US) 2016-12-14 EP disclosed
US-20160347694-A1 INTEGRATED PROCESS FOR THE PRODUCTION OF Z-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE THE CHEMOURS COMPANY FC, LLC (DE) 2016-12-01 US disclosed
US-9440896-B2 Dehydrochlorination of HCFC-336 isomers to 1,1,1,4,4,4-hexafluoro-2-butyne THE CHEMOURS COMPANY FC, LLC (US) 2016-09-13 US disclosed
US-9199961-B2 Preparation of caprolactone, caprolactam, 2,5-tetrahydrofuran-dimethanol, 1,6-hexanediol or 1,2,6-hexanetriol from 5-hydroxymethyl-2-furfuraldehyde NEDERLANDSE ORGANISATIE VOOR WETENSCHAPPELIJK ONDERZOEK (NWO) (NL) 2015-12-01 US disclosed
EP-2922809-A1 DEHYDROCHLORINATION OF CHLORINATED REACTANTS TO PRODUCE 1,1,1,4,4,4-HEXAFLUORO-2-BUTYNE E. I. du Pont de Nemours and Company (US) 2015-09-30 EP disclosed
WO-2015142981-A1 PROCESSES FOR THE PRODUCTION OF Z 1,1,1,4,4,4 HEXAFLUORO 2-BUTENE E I DU PONT DE NEMOURS AND COMPANY (US) 2015-09-24 WO disclosed
WO-2015120250-A1 INTEGRATED PROCESS FOR THE PRODUCTION OF Z-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE E. I. DU PONT DE NEMOURS AND COMPANY (US) 2015-08-13 WO disclosed
US-20150203423-A1 Dehydrochlorination of HCFC -336 Isomers to 1,1,1,4,4,4-Hexafluoro-2-Butyne E I DU PONT DE NEMOURS AND COMPANY (US) 2015-07-23 US disclosed
US-20150165074-A1 METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF LANTHEUS MEDICAL IMAGING, INC. (US) 2015-06-18 US disclosed
US-8936777-B2 Methods and apparatus for synthesizing imaging agents, and intermediates thereof LANTHEUS MEDICAL IMAGING, INC. (US) 2015-01-20 US disclosed
US-20140228564-A1 PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2014-08-14 US disclosed
US-8680335-B2 Processes of enantioselectively forming an aminoxy compound and an 1,2-oxazine compound NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2014-03-25 US disclosed
US-20130137863-A1 Preparation of caprolactone, caprolactam, 2,5-tetrahydrofuran-dimethanol, 1,6-hexanediol or 1,2,6-hexanetriol from 5-hydroxymethyl-2-furfuraldehyde NEDERLANDSE ORGANISATIE VOOR WETENSCHAPPELIJK ONDERZOEK (NWO) (NL) 2013-05-30 US disclosed
EP-2576506-A1 PREPARATION OF CAPROLACTONE, CAPROLACTAM, 2,5-TETRAHYDROFURAN-DIMETHANOL, 1,6-HEXANEDIOL OR 1,2,6-HEXANETRIOL FROM 5-HYDROXYMETHYL-2-FURFURALDEHYDE Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) (NL) 2013-04-10 EP disclosed
US-20130064769-A1 METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF LANTHEUS MEDICAL IMAGING, INC (US) 2013-03-14 US disclosed
EP-2534136-A2 METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF Lantheus Medical Imaging, Inc. (US) 2012-12-19 EP disclosed
WO-2011149339-A1 PREPARATION OF CAPROLACTONE, CAPROLACTAM, 2,5-TETRAHYDROFURAN-DIMETHANOL, 1,6-HEXANEDIOL OR 1,2,6-HEXANETRIOL FROM 5-HYDROXYMETHYL-2-FURFURALDEHYDE NETHERLANDS ORGANISATION FOR SCIENTIFIC RESEARCH (ADVANCED CHEMICAL TECHNOLOGIES FOR SUSTAINABILITY) (NL) 2011-12-01 WO disclosed
EP-2390247-A1 Preparation of caprolactone, caprolactam, 2,5-tetrahydrofuran dimethanol, 1,6-hexanediol or 1,2,6-hexanetriol from 5-hydroxymethyl-2-furfuraldehyde Netherlands Organisation for Scientific Research (Advanced Chemical Technologies for Sustainability) (NL) 2011-11-30 EP disclosed
US-20110257334-A1 Switchable Hydrophilicity Solvents and Methods of Use Thereof QUEEN'S UNIVERSITY AT KINGSTON (CA) 2011-10-20 US disclosed
US-20110224429-A1 PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2011-09-15 US disclosed
WO-2011097649-A2 METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF LANTHEUS MEDICAL IMAGING, INC. (US) 2011-08-11 WO disclosed
US-7696366-B2 Production process of bifunctional epoxy monomer by selective oxidation of diolefin compound SHOWA DENKO K.K. (JP) 2010-04-13 US disclosed
US-7615656-B2 Cycloaliphatic polyepoxy compounds and preparation thereof DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2009-11-10 US disclosed
US-7578971-B2 methyltricaprylylammonium phenoxide as phase transfer agent, pH sensitive color indicator is thymol blue, and ethoxylated alcohol is octylphenol ethoxylate; polyethersulfone as a solid support; excellent resistance to humidity; located in an esophageal breathing system MERCURY ENTERPRISES, INC. (US) 2009-08-25 US disclosed
EP-1891031-B1 PRODUCTION PROCESS OF BIFUNCTIONAL EPOXY MONOMER BY SELECTIVE OXIDATION OF DIOLEFIN COMPOUND SHOWA DENKO KK (JP) 2009-03-11 EP disclosed
US-20090030217-A1 PRODUCTION PROCESS OF BIFUNCTIONAL EPOXY MONOMER BY SELECTIVE OXIDATION OF DIOLEFIN COMPOUND SHOWA DENKO K.K. (JP) 2009-01-29 US disclosed
EP-1891031-A2 PRODUCTION PROCESS OF BIFUNCTIONAL EPOXY MONOMER BY SELECTIVE OXIDATION OF DIOLEFIN COMPOUND Showa Denko K.K. (JP) 2008-02-27 EP disclosed
US-20080004425-A1 Cycloaliphatic polyepoxy compounds and prepartation thereof DAICEL CHEMICAL INDUSTRIES, LTD. 2008-01-03 US disclosed
EP-1873149-A1 Cycloaliphatic polyepoxy compounds and preparation thereof Daicel Chemical Industries, Ltd. (JP) 2008-01-02 EP disclosed
WO-2006123814-A2 PRODUCTION PROCESS OF BIFUNCTIONAL EPOXY MONOMER BY SELECTIVE OXIDATION OF DIOLEFIN COMPOUND SHOWA DENKO K.K. (JP) 2006-11-23 WO disclosed
US-20060216828-A1 Rapid-response reversible dry surface CO2 detector MERCURY ENTERPRISE, INC. 2006-09-28 US disclosed
EP-1217011-B1 Process for producing an expoxidized polymer KURARAY CO (JP) 2005-10-12 EP disclosed
US-6541575-B2 Epoxidation of polymer having olefinic carbon-carbon double in absence of alkali metal by adding aqueous solution of ammonium tungstate and/or tungstophosphoric acid and phosphoric acid, adding hydrogen peroxide and quternary ammonium salt KURARAY CO., LTD. (JP) 2003-04-01 US disclosed
US-20020082348-A1 Process for producing an epoxidized polymer KURARAY CO. LTD, (JP) 2002-06-27 US disclosed
EP-1217011-A1 Process for producing an expoxidized polymer KURARAY CO., LTD. (JP) 2002-06-26 EP disclosed
EP-1217011-A1 Process for producing an expoxidized polymer KURARAY CO., LTD. (JP) 2002-06-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (24 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257334-A1 Switchable Hydrophilicity Solvents and Methods of Use Thereof AQP4, AQP1, AQP3 SLC22A1 565/4885ALDH1A1 4318/4885TP53 91/4885
US-20190290788-A1 METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF TNNI3, FABP3, MPI SLC22A1 1381/4885ALDH1A1 1208/4885TP53 2551/4885
US-20210187131-A1 METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF TNNI3, FABP3, MPI SLC22A1 1381/4885ALDH1A1 1208/4885TP53 2551/4885
US-20250242063-A1 METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF TNNI3, FABP3, MPI SLC22A1 1381/4885ALDH1A1 1208/4885TP53 2551/4885
US-11912639-B2 Processes for producing Z-1,1,1,4,4,4-hexafluorobut-2-ene and intermediates for producing same CPNE4, HCFC1, HVCN1 SLC22A1 2608/4885ALDH1A1 387/4885TP53 2480/4885
US-12421181-B2 Process for producing 1,1,1,4,4,4-hexafluorobut-2-ene HVCN1, HCFC1, EPB41 SLC22A1 2828/4885ALDH1A1 421/4885TP53 3445/4885
US-20260042721-A1 PROCESS FOR PRODUCING 1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE AFF1, AP2A1, SLC9A1 SLC22A1 2846/4885ALDH1A1 734/4885TP53 1558/4885
US-20130137863-A1 Preparation of caprolactone, caprolactam, 2,5-tetrahydrofuran-dimethanol, 1,6-hexanediol or 1,2,6-hexanetriol from 5-hydroxymethyl-2-furfuraldehyde HPD, DHPS, MTHFD2 SLC22A1 4599/4885ALDH1A1 177/4885TP53 2559/4885
US-10022462-B2 Methods and apparatus for synthesizing imaging agents, and intermediates thereof TNNI3, FABP3, MPI SLC22A1 1381/4885ALDH1A1 1208/4885TP53 2551/4885
US-20220194879-A1 PROCESSES FOR PRODUCING Z-1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE AND INTERMEDIATES FOR PRODUCING SAME CPNE4, HCFC1, HVCN1 SLC22A1 2608/4885ALDH1A1 387/4885TP53 2480/4885
US-20220194882-A1 PROCESSES FOR PRODUCING Z-1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE AND INTERMEDIATES FOR PRODUCING SAME CPNE4, HCFC1, HVCN1 SLC22A1 2739/4885ALDH1A1 467/4885TP53 3234/4885
US-20110224429-A1 PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND AHR, CYP2S1, CYP1A1 SLC22A1 3282/4885ALDH1A1 354/4885TP53 4672/4885
US-20250171409-A1 PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES DDT, IDO2, INSR SLC22A1 3135/4885ALDH1A1 1545/4885TP53 4475/4885
US-20220194881-A1 PROCESSES FOR PRODUCING Z-1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE AND INTERMEDIATES FOR PRODUCING SAME CPNE4, HVCN1, ZYX SLC22A1 2518/4885ALDH1A1 1083/4885TP53 3382/4885
US-20150165074-A1 METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF TNNI3, FABP3, MPI SLC22A1 1381/4885ALDH1A1 1208/4885TP53 2551/4885
US-12421180-B2 Processes for producing Z-1,1,1,4,4,4-hexafluorobut-2-ene and intermediates for producing same CPNE4, HCFC1, HVCN1 SLC22A1 2739/4885ALDH1A1 467/4885TP53 3234/4885
US-20130064769-A1 METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF TNNI3, FABP3, MPI SLC22A1 1381/4885ALDH1A1 1208/4885TP53 2551/4885
US-10842892-B2 Methods and apparatus for synthesizing imaging agents, and intermediates thereof TNNI3, FABP3, MPI SLC22A1 1381/4885ALDH1A1 1208/4885TP53 2551/4885
US-12286386-B2 Process to produce (Z)-1,1,1,4,4,4-hexafluoro-2-butene and intermediates ZYX, TMEM14C, ZRANB2 SLC22A1 2316/4885ALDH1A1 1926/4885TP53 2937/4885
US-20140228564-A1 PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND AHR, CYP2S1, CYP1A1 SLC22A1 3282/4885ALDH1A1 354/4885TP53 4672/4885
US-20170258947-A1 METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF TNNI3, FABP3, MPI SLC22A1 1381/4885ALDH1A1 1208/4885TP53 2551/4885
US-20220162141-A1 PROCESS FOR PRODUCING 1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE HVCN1, HCFC1, EPB41 SLC22A1 2828/4885ALDH1A1 421/4885TP53 3445/4885
US-20090030217-A1 PRODUCTION PROCESS OF BIFUNCTIONAL EPOXY MONOMER BY SELECTIVE OXIDATION OF DIOLEFIN COMPOUND DUOX2, DUOX1, DDT SLC22A1 4869/4885ALDH1A1 747/4885TP53 4878/4885
US-20230074227-A1 PROCESS TO PRODUCE (Z)-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE AND INTERMEDIATES ZYX, TMEM14C, ZRANB2 SLC22A1 2316/4885ALDH1A1 1926/4885TP53 2937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.